In the third quarter of 2024, investment titan Blackrock released a commentary on the market outlook for artificial ...

Linda Llewelyn, the Chief People Officer at Health Catalyst , Inc. (NASDAQ:HCAT), recently sold shares of the company, according to a filing with the Securities and Exchange Commission. On January 15, ...

Investing.com -- Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial ...

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...

Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...

Major U.S. indexes were little changed at midday Thursday after Wednesday's big gains powered by strong bank earnings and a ...

Thursday's trading session has presented significant movements among stocks, particularly within the mega-cap and large-cap segments. Market participants have witnessed notable declines in heavyweight ...

Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...

Learn about Healwell AI Inc.'s growth strategy in the healthcare AI sector in Canada, projected to reach USD $10.7 billion by ...

What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...

Crude oil futures settle higher on the first trading day of the year amid some optimism about the outlook for the Chinese economy, while outsized U.S. product inventory builds looked bearish. U.S ...

An analysis by natey1015 on ValueInvestorsClub offers a bearish perspective for CVS Health, a stock that has fallen by almost 60% in the last three years. CVS shares were trading at $62.92 when ...